Companies / Icosavax, Inc.
Icosavax, Inc.
ICVXCIK 1786255
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $37.42M | +2.5M +94.30% | 5,140,679 | high |
| Aug 2, 2021 | Qiming U.S. Healthcare Fund II, L.P. Director | Buy Open-market buy | Common Stock | $3.00M | +200K +6.04% | 3,510,228 | high |
| Aug 2, 2021 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $2.58M | +172K +36.79% | 638,668 | high |
| Aug 2, 2021 | NanoDimension III, L.P. 10% owner | Buy Open-market buy | Common Stock | $2.00M | +133K +4.85% | 2,883,329 | high |
| Jul 30, 2021 | Simpson Adam K. CEO | Grant Grant or award | Common Stock | $1.88M | +125K | 125,000 | low |
| Jan 4, 2023 | Kanesa-thasan Niranjan Executive | Sell Open-market sale | Common Stock | $1.67M | -106K -32.20% | 223,980 | medium |
| Aug 2, 2021 | Sanofi 10% owner | Buy Open-market buy | Common Stock (par value, $0.0001) | $1.00M | +67K +2.16% | 3,155,169 | high |
| Dec 20, 2023 | Simpson Adam K. CEO | Sell Open-market sale | Common Stock | $961.5K | -62K -25.19% | 184,724 | medium |